Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-28

Clinical Trial Update: Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant [Phase 2]

View source ↗

Summary

Phase 2 trial comparing generic pegfilgrastim to brand-name pegfilgrastim for neutrophil recovery after autologous transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Hospital Universitario Dr. Jose E. Gonzalez | Conditions: Myeloma Multiple, Lymphoma | Phase 2 | Status: COMPLETED